WallStSmart
PLRZ

Polyrizon Ltd. Ordinary Shares

NASDAQ: PLRZ · HEALTHCARE · BIOTECHNOLOGY

$10.78
+2.52% today

Updated 2026-09-25

Market cap
$26.16M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.89
Dividend yield
—
52W range
$3 – $18
Volume
0.1M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
7.3
Quality
B+
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
27.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →261 stocks currently score above 75

Price targets

Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
+ Altman Z 27.62 — safe zone
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-2.71M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00—
Net income$-779000.00$-600000.00$-1.54M$-3.33M$-3.16M
EPS————$-4.89
Free cash flow$-1.14M$-537000.00$-1.15M$-4.54M$-2.71M
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PLRZ$26.16M234.33.05.07.3—Avoid
LLY$1.03T769.310.05.06.0—Strong Buy
JNJ$648.67B594.78.53.75.5—Buy
ABBV$454.36B736.78.54.05.0-73.51%Strong Buy
MRK$365.34B364.04.52.05.0-78.20%Hold
UNH$333.27B627.35.55.35.5-14.85%Buy

Smart narrative

Polyrizon Ltd. Ordinary Shares trades at $10.78. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 27.62, it sits in the safe zone.

Frequently asked questions

What is Polyrizon Ltd. Ordinary Shares's stock price?

Polyrizon Ltd. Ordinary Shares (PLRZ) trades at $10.78.

Is Polyrizon Ltd. Ordinary Shares overvalued?

Polyrizon Ltd. Ordinary Shares carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Polyrizon Ltd. Ordinary Shares's Altman Z-Score is 27.62, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-19.60%
Beta—
50D MA$12.10
200D MA$12.73
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—